Event Summary
Both Congress and the National Institutes of Health have been actively engaged in reviewing conflict of interest policies for government researchers. This AEI-Brookings Joint Center symposium will focus on the implications for university-industry relations and feature a new working paper on those relationships by three of the leading experts in the field—Professors David Blumenthal, Eric Campbell, and Greg Koski of Harvard University. The paper pays special attention to this issue in the context of emerging drug discovery and development practices in the pharmaceutical and biotechnology industries.
Introductory Remarks:
DAVID J. GOLDSTON
Chief of Staff, House Science Committee, Office of Congressman Sherwood Boehlert (R - N.Y.)
ROBERT HAHN
Executive director, AEI-Brookings Joint Center
Moderator:
ROBERT LITAN
Director, AEI-Brookings Joint Center; Senior Fellow, Economic Studies, Brookings; Vice President for Research and Policy, The Kauffman Foundation
Presenter:
GREG KOSKI
Associate Professor of Anesthesia, Harvard Medical School;
Senior Scientist, Institute for Health Policy, Massachusetts General Hospital
Discussants:
GAIL CASSELL
Vice President, Scientific Affairs, and Distinguished Research Scholar in Infectious Diseases, Eli Lilly and Company
WILLIAM HASELTINE
Founder, Chairman of the Board, and CEO, Human Genome Sciences
THOMAS H. MURRAY
President and CEO, The Hastings Center